Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

OBJECTIVE: To compare incidences of neuroinflammatory events, including demyelinating disease (DML), inflammatory polyneuropathies (IPN) and multiple sclerosis (MS), in patients with rheumatoid arthritis (RA) or spondyloarthritis (SpA; including psoriatic arthritis) starting a tumour necrosis factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Delcoigne, Benedicte, Kopp, Tine Iskov, Arkema, Elizabeth V, Hellgren, Karin, Provan, Sella Aarrestad, Relas, Heikki, Aaltonen, Kalle, Trokovic, Nina, Gudbjornsson, Bjorn, Grondal, Gerdur, Klami Kristianslund, Eirik, Lindhardsen, Jesper, Dreyer, Lene, Askling, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980369/
https://www.ncbi.nlm.nih.gov/pubmed/36854568
http://dx.doi.org/10.1136/rmdopen-2022-002924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980369/
https://www.ncbi.nlm.nih.gov/pubmed/36854568
http://dx.doi.org/10.1136/rmdopen-2022-002924

Ejemplares similares